Literature DB >> 24829112

Treating thrombosis in cirrhosis patients with new oral agents: ready or not?

Nicolas M Intagliata1, Hillary Maitland, Patrick G Northup, Stephen H Caldwell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24829112     DOI： 10.1002/hep.27225

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  13 in total

1.  Direct oral anticoagulants in rare venous thrombosis.

Authors:  Guido Finazzi; Walter Ageno
Journal:  Intern Emerg Med       Date:  2016-02-13       Impact factor: 3.397

Review 2.  Portal vein thrombosis in cirrhosis: Controversies and latest developments.

Authors:  Damian J Harding; M Thamara P R Perera; Frederick Chen; Simon Olliff; Dhiraj Tripathi
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

3.  Portal vein thrombosis in patients with cirrhosis: underdiagnosis and undertreatment?

Authors:  Aaron Liew; James Douketis
Journal:  Intern Emerg Med       Date:  2016-05-23       Impact factor: 3.397

4.  Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar Risks of Bleeding When Compared to Traditional Anticoagulation.

Authors:  N M Intagliata; Z H Henry; H Maitland; N L Shah; C K Argo; P G Northup; S H Caldwell
Journal:  Dig Dis Sci       Date:  2016-01-02       Impact factor: 3.199

Review 5.  Role of the blood coagulation cascade in hepatic fibrosis.

Authors:  Asmita Pant; Anna K Kopec; James P Luyendyk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-05-03       Impact factor: 4.052

6.  Portal vein thrombosis, mortality and hepatic decompensation in patients with cirrhosis: A meta-analysis.

Authors:  Jonathan G Stine; Puja M Shah; Scott L Cornella; Sean R Rudnick; Marwan S Ghabril; George J Stukenborg; Patrick G Northup
Journal:  World J Hepatol       Date:  2015-11-28

7.  Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference.

Authors:  N M Intagliata; C K Argo; J G Stine; T Lisman; S H Caldwell; F Violi
Journal:  Thromb Haemost       Date:  2018-07-30       Impact factor: 5.249

8.  Hypercoagulability in End-stage Liver Disease: Review of Epidemiology, Etiology, and Management.

Authors:  Thomas A Verbeek; Jonathan G Stine; Fuat H Saner; Dmitri Bezinover
Journal:  Transplant Direct       Date:  2018-10-26

9.  Safety of direct oral anticoagulants in patients with mild to moderate cirrhosis: a systematic review and meta-analysis.

Authors:  Sarah A Nisly; Alexandra E Mihm; Chris Gillette; Kyle A Davis; Janine Tillett
Journal:  J Thromb Thrombolysis       Date:  2021-03-16       Impact factor: 2.300

Review 10.  Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challenges.

Authors:  Aikaterini Mantaka; Aikaterini Augoustaki; Elias A Kouroumalis; Dimitrios N Samonakis
Journal:  Ann Gastroenterol       Date:  2018-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.